Sylvester Comprehensive Cancer Center

E-mail a Friend

John J. Byrnes, M.D.

General Information

John J. Byrnes, M.D.

Languages

  • English

Certifications

  • American Bd of Internal Med-Diagnostic Laboratory Immunol
  • American Board of Internal Medicine
  • American Board of Internal Med-Hematology
  • American Board of Internal Med-Medical Oncology

CV

Specialties

  • Hematology/Oncology - Internal Medicine
  • Internal Medicine

Roles

  • Professor of Medicine

Clinical Interests

Hematologic Malignancies-Leukemia
Lymphoma, Myeloma
Bone Marrow Transplant
Benign Hematology

Research Interests

Mechanism and treatment of thrombotic microangiopathy syndromes, including thrombocytic thrombocytopenia purpura (TTP) and hemolytic-uremic syndrome (HUS)

Education

Undergraduate
College of the Holy Cross
Graduate
Tufts University School of Medicine
Internship
State University of NY at Buffalo
Residency
State University of NY at Buffalo
Fellowship
University of Miami

Publications

  • Warsch,S and Byrnes,J. Emerging causes of iron deficiency anemia refractory to iron supplementation. World Journal of Gastroenterology. Accepted for publication
  • Hare, J M, et al. Byrnes J, et al. Heldman AW. Comparison of Allogenic vs. Autologous Bone Marrow Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy . JAMA 2012 Nov 6:: 1-11
  • Trachtenberg B, et al…Byrnes J, Zambrano J, Heldman A, Hare J. Rational and design of the Transendocardial Injection or Autologous Human Cells )bone marrow or mesenchymal) in Chronic Left Ventricular Dysfunctional and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double–blinded, placebo controlled study of safety and efficacy. American Heart Journal, 2011; 161 (3):487-93
  • Escalon MP, Stefanovic A, Venkatraman A, Pereira D, Santos ES, Goodman M, Byrnes JJ, Fernandez, HF. Autologous transplantation for relapsed non-Hodgkin’s lymphoma using intravenous busulfan and cyclophosphamide as a conditioning regimen. Bone Marrow Transplant. 2009; 44 (2):89-96
  • Massiri M, Byrne GE, Whitcomb CC, Byrnes JJ Synchronous null-cell anaplastic large cell lymphoma and multiple myeloma Ann Hematol 88:923-925 ,2009

E-mail a Friend